New 9-Month pill combo could beat Drug-Resistant TB
Disease control
Not yet recruiting
This study tests a 9-month, all-oral drug combination (BLMZ) for people with rifampicin-resistant tuberculosis (TB). About 120 participants aged 12 and older will take the pills and be followed for 24 months to see if the infection clears and stays gone. The goal is to find a sho…
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC